Medical News: Update on Vasomotor Symptoms (Hot Flashes)
Two studies, that reported results earlier this week, are shedding more light into some of the mysteries of menopausal health: 1) RANKL Proteins linked to thermoregulation and implicated in Hot Flashes.It has been widely known that RANKL proteins play a significant role in osteoporosis, but a recent animal study, published in Nature, suggests that it also plays a role in thermo-regulation, and maybe even hot flashes. Both hot flashes and osteoporosis are common menopausal symptoms. 2) Black Cohosh is not effective for the treatment of Hot FlashesA 351 patient, double-blind, placebo-controlled clincal trial, published in the Annals of Internal Medicine, confirms that, yet again, Black Coho

Bionovo: novel approach, challenges ahead, but poised to move higher
The Women’s Health Initiative (WHI), a study that demonstrated several lethal side-effects of hormone replacement therapy (HRT), has left many pharmaceutical companies scrambling to advance alternative therapies to meet the unique market demand created by the drop in hormone sales. Although several therapies have advanced to late-stage clinical studies, few represent a truly novel approach. Pristiq, Wyeth’s new treatment for depression and potentially –post menopausal hot flashes, is merely a metabolite of the multi-billion dollar blockbuster, Effexor. Aprella, Wyeth’s investigational combination product for the treatment of menopausal symptoms, repackages two commonly used clas

Serada Half Price Sale: DepoMed's Stock Price Poised to Climb
Several weeks ago, DepoMed (NASDAQ:DEPO), a specialty pharmaceutical company, announced positive phase 3 trial results for the treatment of Post Herpetic Neuralgia (‘PHN’) with DM1796. But DepoMed’s news of success was soon eclipsed. Only one week later, the company announced that Serada didn’t meet its primary endpoints in two pivotal Phase 3 clinical trials for the treatment of vasomotor symptoms, more commonly known as hot flashes. Since the upsetting trial data, DepoMed’s stock price has tanked over 50%, yet not one majority-shareholder has sold any shares. Could it be that “smart money” sees something that the ‘market’ doesn’t see? Obviously, the ‘BREEZE’ tri

Three Brothers Health - September/October Reconstruction & Hiatus
We will be back soon. We are taking a month long hiatus, and will be back in late October of early November. Feel free to contact us in the meantime. ~Three Brothers Health Visit our site to finish the article: http://www.threebrothershealth.com

Falling Off And Getting Back On, What I'll Need To Work Through This
I've fallen off. Now I'm not admitting failure or defeat in any way, but considering the tone and attitude of my last post, I should have reached a certain milestone in my progress with the transformation of my body and mind. I had a high school football coach who, in as little words as possible, made me dread football practice as much as a little kid does the dentist (I still dread the dentist as an adult taking into account the recent work that I’ve had done and the large void in my bank account). Back to the old coach, who is as pretty much as close as you could get to the sergeant from that movie Full Metal Jacket. One of his many one liners (and there were many) was the good ol "excu